Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1335002-97-5

Post Buying Request

1335002-97-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1335002-97-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1335002-97-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,5,0,0 and 2 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1335002-97:
(9*1)+(8*3)+(7*3)+(6*5)+(5*0)+(4*0)+(3*2)+(2*9)+(1*7)=115
115 % 10 = 5
So 1335002-97-5 is a valid CAS Registry Number.

1335002-97-5Downstream Products

1335002-97-5Relevant articles and documents

GLYCOSIDE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF AS PROSTHETIC GROUPS

-

Paragraph 0096-0099, (2016/04/02)

The present invention relates to glycoside-derived compounds, to the processes for preparing same and to the use thereof as prosthetic groups for radiolabelling biomolecules. These compounds are co-azido-alkyl 6-deoxy-6-[18F]-fluoroglycosides of formula (I), in which: k is equal to 2 or 3; n is an integer between 1 and 5; R is independently H or a C1-C5 alkyl group, m being an integer between 0 and 2 if k=2 and m between 0 and 3 if k=3; and X is chosen from the group comprising O, S, CH2 and NR′, in which R′ is independently a C1-C5 alkyl group or an aryl group, including all the stereoisomers thereof.

Click glycosylation of peptides through cysteine propargylation and CuAAC

Lamandé-Langle, Sandrine,Collet, Charlotte,Hensienne, Rapha?l,Vala, Christine,Chrétien, Fran?oise,Chapleur, Yves,Mohamadi, Amel,Lacolley, Patrick,Regnault, Véronique

, p. 6672 - 6683 (2015/02/19)

'Click' glycosylation of cysteine-containing peptides were carried out in good yield by Copper(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC). For that peptides were functionalized though direct propargylation of the cysteine residue allowing their use in CuAAC with suitable free or protected azido sugars of gluco, manno and galacto configuration. Among these free and protected glycopeptides a series of 'glycoRGD' peptides were obtained and submitted to in vitro platelet aggregation tests, showing that the pseudoglycosylation of the adhesion sequence lowers the IC50 value and thus could improve the in vivo pharmacokinetic properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1335002-97-5